Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nicoleta C. Voian"'
Autor:
Judith Balmaña, Nicoleta C. Voian, Tuya Pal, Joanne Ngeow, Douglas R. Stewart, Myra J. Wick, Paul A. James, Marc Tischkowitz, Rita K. Schmutzler, William D. Foulkes
Publikováno v:
Genetics in Medicine. 23:1416-1423
Purpose PALB2 germline pathogenic variants are associated with increased breast cancer risk and smaller increased risk of pancreatic and likely ovarian cancer. Resources for health-care professionals managing PALB2 heterozygotes are currently limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4b282d8dc93a730b7b42135483845d5
https://doi.org/10.1038/s41436-021-01151-8
https://doi.org/10.1038/s41436-021-01151-8
Autor:
Nicoleta C. Voian, Allison W. Kurian, Georgia L. Wiesner, Beth Crawford, Carolyn Horton, Susan Friedman, Kristen M. Shannon, Saundra S. Buys, Jennifer E. Axilbund, Virginia G. Kaklamani, Robert Pilarski, Judy Garber, Mary B. Daly, Wendy Kohlmann, Rashmi Kumar, Sofia D. Merajver, Alison J. Whelan, Boris Pasche, Catherine Klein, Mary A. Dwyer, Gwen Reiser, P. Kelly Marcom, Lisa Madlensky, Jeffrey N. Weitzel, Jennifer K. Litton, Kenneth Offit, Elizabeth M. Swisher, Tuya Pal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 12:1326-1338
During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian foc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e73b991319a174a60f008b58411d53f
https://doi.org/10.6004/jnccn.2014.0127
https://doi.org/10.6004/jnccn.2014.0127
Publikováno v:
Clinical Journal of Oncology Nursing. 18:E58-E63
The purpose of this study was to evaluate women who have completed hereditary cancer risk assessment and BRCA genetic testing to determine if they considered themselves prepared to proceed with decision making regarding cancer screening and preventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2002f8f2c4f853a257225a7c1fbf0b97
https://doi.org/10.1188/14.cjon.e58-e63
https://doi.org/10.1188/14.cjon.e58-e63
Autor:
Nicoleta C. Voian, Allison W. Kurian, Tuya Pal, Meagan Farmer, Georgia L. Wiesner, Susan Darlow, Judy Garber, Lisa Madlensky, Kristen M. Shannon, Gwen Reiser, Robert Pilarski, Jennifer K. Litton, Kenneth Offit, Seema A. Khan, Elizabeth M. Swisher, Noah D. Kauff, Mary A. Dwyer, Mary B. Daly, Michael Berry, Saundra S. Buys, Sofia D. Merajver, Susan Hatters Friedman, Shaveta Vinayak, Catherine Klein, Myra J. Wick, Wendy Kohlmann, Jeffrey N. Weitzel
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 15(1)
The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d803e83dc52122162f2bb7c5c0999221
https://pubmed.ncbi.nlm.nih.gov/28040716
https://pubmed.ncbi.nlm.nih.gov/28040716
Autor:
Nicoleta C. Voian, Kunle Odunsi, Jean B. Dawidzik, Harold G. Freund, Harold C. Box, Heidi Godoy, Helen B. Patrzyc, Edwin E. Budzinski, Peter J. Frederick
Publikováno v:
Cancer letters. 338(2)
Oxidatively-induced DNA damage was measured in the DNA of WBC from two groups of women: carriers of a BRCA mutation, but asymptomatic for disease, and healthy controls. Two oxidatively induced lesions were measured: a formamide remnant of pyrimidine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df25a284370950ff4d8660d147de50da
https://pubmed.ncbi.nlm.nih.gov/23583677
https://pubmed.ncbi.nlm.nih.gov/23583677
Publikováno v:
Journal of Clinical Oncology. 33:e12501-e12501
e12501 Background: Evaluate the current methodology in clinical genetic testing for HBOC syndromes. Methods: Retrospective review of results of genetic testing in individuals evaluated for HBOC syn...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f18aab7b64970efefa8ed254c9f274c7
https://doi.org/10.1200/jco.2015.33.15_suppl.e12501
https://doi.org/10.1200/jco.2015.33.15_suppl.e12501
Autor:
Robert Pilarski, Mary B. Daly, Saundra S. Buys, Meagan Farmer, Susan Hatters Friedman, Mary A. Dwyer, Mark E. Robson, Jennifer E. Axilbund, Huma Q. Rana, Nicoleta C. Voian, Gwen Reiser, Elizabeth M. Swisher, Allison W. Kurian, P. Kelly Marcom, Georgia L. Wiesner, Beth Crawford, Wendy Kohlmann, Susan Darlow, Sofia D. Merajver, Tuya Pal, Jennifer K. Litton, Kristen M. Shannon, Jeffrey N. Weitzel, Myra J. Wick, Kenneth Offit, Lisa Madlensky, Judy Garber, Michael Berry, Seema A. Khan, Catherine Klein, Rashmi Kumar, Alison J. Whelan
Publikováno v:
Memorial Sloan Kettering Cancer Center
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes. Guidelines focus on syndromes associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df2093fd3d121a4c91b0eb517f76a624
https://synapse.mskcc.org/synapse/works/89306
https://synapse.mskcc.org/synapse/works/89306
